Trius Therapeutics (TSRX) Posts Narrower than Expected Q4 Loss of 44c/Share

Article Stock Quotes (1) Comments (0)

Trius Therapeutics, Inc. (NASDAQ: TSRX) reported Q4 EPS of ($0.44), $0.05 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $3.52 million versus the consensus estimate of $3.82 million.

For earnings history and earnings-related data on Trius Therapeutics, Inc. (TSRX) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
• UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29
• The Bon-Ton Stores, Inc. (BONT) Post Smaller Q1 Loss; Reaffirms Outlook

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?